XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders’ Deficit (unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Treasury Stock
Additional paid-in capital
Accumulated deficit
Preferred stock, beginning balance (in shares) at Dec. 31, 2022   0        
Beginning balance at Dec. 31, 2022 $ 4,052 $ 0 $ 17 $ 0 $ 9,078 $ (5,043)
Common stock, beginning balance (in shares) at Dec. 31, 2022     173,524,360      
Treasury stock, beginning balance (in shares) at Dec. 31, 2022       0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (32,899)         (32,899)
Comprehensive loss (32,899)         (32,899)
Interest on the promissory note to a member (282)       (282)  
Repayment of promissory note to a member 18,833       18,833  
Payment of interest on promissory note to a member 520       520  
Stock-based compensation 3,126       3,126  
Vested restricted stock units (in shares)     21,875      
Exercise of stock options (in shares)     296,477      
Exercise of stock options 1,010       1,010  
Preferred stock, ending balance (in shares) at Mar. 31, 2023   0        
Ending balance at Mar. 31, 2023 $ (5,640) $ 0 $ 17 $ 0 32,285 (37,942)
Common stock, ending balance (in shares) at Mar. 31, 2023     173,842,712      
Treasury stock, ending balance (in shares) at Mar. 31, 2023       0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock, par value (in USD per share)     $ 0.0001      
Preferred stock, par value (in USD per share)   $ 0.0001        
Common stock, par value (in USD per share) $ 0.0001          
Preferred stock, par value (in USD per share) $ 0.0001          
Preferred stock, beginning balance (in shares) at Dec. 31, 2023 0 0        
Beginning balance at Dec. 31, 2023 $ (18,292) $ 0 $ 18 $ (2,154) 44,655 (60,811)
Common stock, beginning balance (in shares) at Dec. 31, 2023 175,020,471   175,377,711      
Treasury stock, beginning balance (in shares) at Dec. 31, 2023       357,240    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (9,406)         (9,406)
Comprehensive loss (9,406)         (9,406)
Stock-based compensation $ 6,259       6,259  
Vested restricted stock units (in shares)     363,793      
Exercise of stock options (in shares) 164,295   164,295      
Exercise of stock options $ 916       916  
Repurchase of common stock for net settlement of equity awards (in shares)       157,276    
Repurchase of common stock for net settlement of equity awards $ (1,494)     $ (1,494)    
Preferred stock, ending balance (in shares) at Mar. 31, 2024 0 0        
Ending balance at Mar. 31, 2024 $ (22,017) $ 0 $ 18 $ (3,648) $ 51,830 $ (70,217)
Common stock, ending balance (in shares) at Mar. 31, 2024 175,391,283   175,905,799      
Treasury stock, ending balance (in shares) at Mar. 31, 2024       514,516    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock, par value (in USD per share) $ 0.0001   $ 0.0001      
Preferred stock, par value (in USD per share) $ 0.0001 $ 0.0001